JSB Market Research - PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022
Marrissa564
2014-06-07
Views 6
During the forecast period from 2012 - 2022, the growth of the UC market will be driven largely by the entry of Johnson & Johnsons (J&Js) Simponi and Takedas Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada.
Report form
RELATED VIDEOS
